Because up to 10% of adults have diabetes and because a substantial proportion will ultimately be prescribed insulin, reports that insulin therapies may be associated with cancer are of significant concern.1,2 This Commentary highlights limitations of the literature and notes that the evidence is also consistent with the hypothesis that insulin therapy targeting good glycemic control might actually reduce cancers.
Gerstein HC. Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?. JAMA. 2010;303(5):446–447. doi:10.1001/jama.2010.60
Customize your JAMA Network experience by selecting one or more topics from the list below.